丙泊酚镇静与布比卡因腰麻用于外倒转术的随机临床试验(PropoSpinECV):随机临床试验研究方案
PropoSpinECV为单中心、随机、开放标签试验,拟纳入所有接受外倒转术的非头位孕妇,比较丙泊酚镇静与布比卡因加芬太尼腰麻在外倒转术中的效果,所有操作均在利托君宫缩抑制下进行。主要结局为外倒转术成功率,同时评估并发症率与术后疼痛,并探讨外倒转术前臀位进展角对手术成功的预测价值。
要点
- 比较丙泊酚镇静与布比卡因腰麻在外倒转术中的成功率。
- 所有操作均在利托君宫缩抑制下进行,并测量术前臀位进展角。
- 主要结局为外倒转术成功率,次要评估并发症率与术后疼痛。
核心结论
- PropoSpinECV试验将全面评估丙泊酚在外倒转术中的有效性。
- 该试验还将探讨外倒转术前臀位进展角作为手术成功预测变量的作用。
研究设计与样本
- PropoSpinECV为单中心、随机、开放标签临床试验。
- 拟纳入所有接受外倒转术的非头位孕妇,按1:1比例分配至丙泊酚镇静组或布比卡因加芬太尼腰麻组。
- 所有操作均在利托君宫缩抑制下进行,并测量所有参与者的外倒转术前臀位进展角。
关键数值与推荐
- 主要结局为外倒转术成功率。
- 同时评估外倒转术并发症率与术后疼痛。
- 试验注册于欧盟临床试验数据库(EU CT号:2024-510701-29-00)和ClinicalTrials.gov数据库(NCT06449430),临床试验注册日期为2024年6月3日。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: External Cephalic Version (ECV) is an effective procedure for modifying fetal position to achieve a cephalic presentation. ECV is usually performed with tocolysis and spinal anesthesia. Recently, propofol has been proposed as a sedative agent for ECV, showing promising results in observational studies. This clinical trial aims to compare the outcomes of ECV performed under tocolysis with either propofol or spinal anesthesia. METHODS: The PropoSpinECV randomized clinical trial is designed as a single-center, randomized, open-label trial. Participation will be offered to every pregnant woman with a non-cephalic presentation undergoing external cephalic version. Sedation with propofol and spinal analgesia with bupivacaine and fentanyl will be compared for ECV with a 1:1 allocation ratio. All procedures will be performed under tocolysis with ritodrine. The breech progression angle before ECV will be measured for all participants. The main outcome will be the ECV success rate. ECV complication rates and post-procedure pain will also be evaluated. DISCUSSION: The PropoSpinECV trial will thoroughly evaluate the efficacy of propofol in ECV. Additionally, this trial will investigate the role of the breech progression angle prior to ECV as a predictive variable for the success of the procedure. TRIAL REGISTRATION: The PropoSpinECV clinical trial is registered in the European Union Clinical Trial Database (EU CT number: 2024-510701-29-00) and in the ClinicalTrials.gov Database (NCT06449430) with the Clinical Trial Registry (2024-06-03).
引用
- Sánchez-Romero J, Falcón-Araña L, Blanco-Carnero JE, et al. Randomized clinical trial of the use of Propofol as a sedative agent versus spinal analgesia with bupivacaine in External Cephalic Version (PropoSpinECV): study protocol for a randomized clinical trial. Trials. 2025. PMID: 41068932. doi:10.1186/s13063-025-09105-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。